CV Therapeutics Inc.  (CVTX) Trade Now »     Rate CVTX  -  Discuss CVTX  -  Add to Watch List        

Sciele Pharma (SCRX) - 7/15/08
LARx (head lice product) NDA
Different mode of action versus current neurotoxic lice killers

Theravance (THRX) - 7/21/08
Telavancin NDA
A good chance for a second approvable letter due to outstanding issues with trial conduct and recent approvable letters for other antibiotics

Warner Chilcott (WCRX) - 7/21/08
Topical alprostadil NDA

Amgen (AMGN) - 7/23/08
Nplate (romiplostim) BLA
Recommended by FDA Oncology Panel (with monitoring of patients)

Medicines Co. (MDCO) - 7/24/08
Angiomax sNDA

Vanda (VNDA)/Titan Pharma (TTP) - 7/27/08
Fanapta (iloperidone) NDA
Read my previ

Filed under: Intel (INTC), JPMorgan Chase (JPM), Potash Corp. of Saskatchewan (POT)

StreetInsider.com After-Hours Movers:

Source Interlink Companies, Inc. (Nasdaq: SORC) 36% HIGHER; reports Q EPS of $0.20, versus $0.18 last year. Revenues for the quarter rose 47.3% to $706.4 million, versus the consensus of $602.5 million.

CV Therapeutics, Inc. (Nasdaq: CVTX) 20% HIGHER; announced that TPG-Axon Capital has agreed to pay CV Therapeutics up to $185 million in exchange for rights to 50 percent of CV Therapeutics' royalty on North American sales of Lexiscan(TM) (regadenoson) injection.

Badger Meter (NYSE: BMI) 13.6% HIGHER; reports Q1 EPS of $0.41, 8 cents better than the anal

Filed under: Before the bell, General Electric (GE), Delta Air Lines (DAL)

General Electric (NYSE:GE) is off 10% on poor earnings and a weak forecast.

CV Therapeutics (NASDAQ:CVTX) is up 18% on approval of one of its products by the FDA.

Delta Airlines (NYSE:DAL) is up 5% on anticipation of a merger with Northwest (NYSE:NWA).

Frontier Air (NASDAQ:FRNT) is off 61% on news of filing Chapter 11.

Stocks may trade differently in the pre-market than they do in the regular session.

Douglas A. McIntyre is an editor at 247wallst.com.

<map name="google_ad_map_145-1164617">